UB Paderborn / Katalog / Suche / in CDI

Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection

International journal of molecular sciences, 2020-01, Vol.21 (2), p.556

2020

Volltextzugriff (PDF)

Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients

Oncology, 2019-03, Vol.96 (3), p.125-131

2019

Volltextzugriff (PDF)

Complications and outcome after free flap surgery for cancer of the head and neck

British journal of oral & maxillofacial surgery, 2018-10, Vol.56 (8), p.684-691

2018

Volltextzugriff (PDF)

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Clinical cancer research, 2008-07, Vol.14 (13), p.4275-4283

2008

Volltextzugriff (PDF)

Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study

Cancers, 2022-05, Vol.14 (9), p.2276

2022

Volltextzugriff (PDF)

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies

BMC medical informatics and decision making, 2021-06, Vol.21 (1), p.205-205, Article 205

2021

Volltextzugriff (PDF)

Bcl-xl and Mcl-1 are the major determinants of the apoptotic response to dual PI3K and MEK blockage

International journal of oncology, 2015-09, Vol.47 (3), p.1103-1110

2015

Volltextzugriff (PDF)

Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients

Journal of cancer research and clinical oncology, 2018-08, Vol.144 (8), p.1613-1621

2018

Volltextzugriff (PDF)

Alternative dosing of dual PI3K and MEK inhibition in cancer therapy

BMC cancer, 2012-12, Vol.12 (1), p.612-612, Article 612

2012

Volltextzugriff (PDF)

Tonsillar microbiota in children with PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome

European journal of clinical microbiology & infectious diseases, 2016-06, Vol.35 (6), p.963-970

2016

Volltextzugriff (PDF)

805: Cancer stem cell-like cells mediate adaptive resistance to targeted cancer therapies

European journal of cancer (1990), 2014-07, Vol.50, p.S194-S195

2014

Volltextzugriff (PDF)

The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer

Cancer medicine (Malden, MA), 2023-08, Vol.12 (15), p.16087-16097

2023

Volltextzugriff (PDF)

A simple novel prognostic model for early stage oral tongue cancer

International journal of oral and maxillofacial surgery, 2015-02, Vol.44 (2), p.143-150

2015

Volltextzugriff (PDF)

Predicting Objective Response Rate (ORR) in Immune Checkpoint Inhibitor (ICI) Therapies with Machine Learning (ML) by Combining Clinical and Patient-Reported Data

Applied sciences, 2022-02, Vol.12 (3), p.1563

2022

Volltextzugriff (PDF)

MEK and PI3K inhibition in solid tumors: rationale and evidence to date

Therapeutic Advances in Medical Oncology, 2015-05, Vol.7 (3), p.170-180

2015

Volltextzugriff (PDF)

Short- and long-term mortality and causes of death after reconstruction of cancers of the head and neck with free flaps

British journal of oral & maxillofacial surgery, 2019-01, Vol.57 (1), p.21-28

2019

Volltextzugriff (PDF)

PO-063: Waiting time and fast track model for head and neck cancer patients in Finland

Radiotherapy and oncology, 2017-03, Vol.122, p.31-32

2017

Volltextzugriff (PDF)

Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study

Acta oncologica, 2023-12, Vol.62 (12), p.1854-1861

2023

Volltextzugriff (PDF)

Association of diagnostic delays to survival in lung cancer: single center experience

Acta oncologica, 2019-07, Vol.58 (7), p.1056-1061

2019

Volltextzugriff (PDF)

Craniomaxillofacial osteosarcoma — The role of surgical margins

Journal of cranio-maxillo-facial surgery, 2019-06, Vol.47 (6), p.922-925

2019

Volltextzugriff (PDF)

Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer

Scientific reports, 2019-07, Vol.9 (1), p.10961-9, Article 10961

2019

Volltextzugriff (PDF)

Recurrent acute otitis media detracts from health-related quality of life

Journal of laryngology and otology, 2017-02, Vol.131 (2), p.128-137

2017

Volltextzugriff (PDF)

ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study

Journal of cancer research and clinical oncology, 2019-03, Vol.145 (3), p.765-774

2019

Volltextzugriff (PDF)

Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers

Journal of cancer research and clinical oncology, 2020-08, Vol.146 (8), p.2153-2160

2020

Volltextzugriff (PDF)

Role of human epidermal growth factor receptor 3 in treatment resistance of anaplastic lymphoma kinase translocated non-small cell lung cancer

Cancer biology & therapy, 2023-12, Vol.24 (1), p.2256906-2256906

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection

Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients

Complications and outcome after free flap surgery for cancer of the head and neck

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies

Bcl-xl and Mcl-1 are the major determinants of the apoptotic response to dual PI3K and MEK blockage

Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients

Alternative dosing of dual PI3K and MEK inhibition in cancer therapy

Tonsillar microbiota in children with PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome

805: Cancer stem cell-like cells mediate adaptive resistance to targeted cancer therapies

The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer

A simple novel prognostic model for early stage oral tongue cancer

Predicting Objective Response Rate (ORR) in Immune Checkpoint Inhibitor (ICI) Therapies with Machine Learning (ML) by Combining Clinical and Patient-Reported Data

MEK and PI3K inhibition in solid tumors: rationale and evidence to date

Short- and long-term mortality and causes of death after reconstruction of cancers of the head and neck with free flaps

PO-063: Waiting time and fast track model for head and neck cancer patients in Finland

Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study

Association of diagnostic delays to survival in lung cancer: single center experience

Craniomaxillofacial osteosarcoma — The role of surgical margins

Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer

Recurrent acute otitis media detracts from health-related quality of life

ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study

Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers

Role of human epidermal growth factor receptor 3 in treatment resistance of anaplastic lymphoma kinase translocated non-small cell lung cancer

Suchergebnisse filtern